These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 24025102)

  • 1. Molecular imaging of apoptosis for early prediction of therapy efficiency.
    De Saint-Hubert M; Bauwens M; Mottaghy FM
    Curr Pharm Des; 2014; 20(14):2319-28. PubMed ID: 24025102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticancer therapy and apoptosis imaging.
    Yang TJ; Haimovitz-Friedman A; Verheij M
    Exp Oncol; 2012 Oct; 34(3):269-76. PubMed ID: 23070012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multimodality molecular imaging of apoptosis in oncology.
    Blankenberg FG; Norfray JF
    AJR Am J Roentgenol; 2011 Aug; 197(2):308-17. PubMed ID: 21785075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiolabeled apoptosis imaging agents for early detection of response to therapy.
    Ogawa K; Aoki M
    ScientificWorldJournal; 2014; 2014():732603. PubMed ID: 25383382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SPECT and PET radiopharmaceuticals for molecular imaging of apoptosis: from bench to clinic.
    Wang X; Feng H; Zhao S; Xu J; Wu X; Cui J; Zhang Y; Qin Y; Liu Z; Gao T; Gao Y; Zeng W
    Oncotarget; 2017 Mar; 8(12):20476-20495. PubMed ID: 28108738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis imaging to monitor cancer therapy: the road to fast treatment evaluation?
    De Saint-Hubert M; Bauwens M; Verbruggen A; Mottaghy FM
    Curr Pharm Biotechnol; 2012 Mar; 13(4):571-83. PubMed ID: 22214506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of Early Response Monitoring and Prediction of Cancer Antiangiogenesis Therapy via Noninvasive PET Molecular Imaging Strategies of Multifactorial Bioparameters.
    Bao X; Wang MW; Luo JM; Wang SY; Zhang YP; Zhang YJ
    Theranostics; 2016; 6(12):2084-2098. PubMed ID: 27698942
    [No Abstract]   [Full Text] [Related]  

  • 9. Application of molecular imaging technologies in antitumor drug development and therapy.
    Lin Y; Chen ZY; Yang F; Zhang JS; Wang YX; Liu JB; Liao JY; Liao YY; Zhou QL; Li BC; Liang HY
    Curr Pharm Des; 2015; 21(16):2136-46. PubMed ID: 25578891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (99m)Tc-Annexin A5 quantification of apoptotic tumor response: a systematic review and meta-analysis of clinical imaging trials.
    Belhocine TZ; Blankenberg FG; Kartachova MS; Stitt LW; Vanderheyden JL; Hoebers FJ; Van de Wiele C
    Eur J Nucl Med Mol Imaging; 2015 Dec; 42(13):2083-97. PubMed ID: 26275392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of radionuclide probes for monitoring anti-tumor drugs efficacy: A brief review.
    Fernandes RS; de Aguiar Ferreira C; Soares DCF; Maffione AM; Townsend DM; Rubello D; de Barros ALB
    Biomed Pharmacother; 2017 Nov; 95():469-476. PubMed ID: 28865367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The progress and promise of molecular imaging probes in oncologic drug development.
    Kelloff GJ; Krohn KA; Larson SM; Weissleder R; Mankoff DA; Hoffman JM; Link JM; Guyton KZ; Eckelman WC; Scher HI; O'Shaughnessy J; Cheson BD; Sigman CC; Tatum JL; Mills GQ; Sullivan DC; Woodcock J
    Clin Cancer Res; 2005 Nov; 11(22):7967-85. PubMed ID: 16299226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive positron emission tomography imaging of cell death using a novel small-molecule probe, (18)F labeled bis(zinc(II)-dipicolylamine) complex.
    Wang H; Tang X; Tang G; Huang T; Liang X; Hu K; Deng H; Yi C; Shi X; Wu K
    Apoptosis; 2013 Aug; 18(8):1017-27. PubMed ID: 23613106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 99mTc-Annexin A5 uptake and imaging to monitor chemosensitivity.
    Belhocine TZ; Blankenberg FG
    Methods Mol Med; 2005; 111():363-80. PubMed ID: 15911991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring of treatment-induced apoptosis in oncology with PET and SPECT.
    Blankenberg FG
    Curr Pharm Des; 2008; 14(28):2974-82. PubMed ID: 18991713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiolabelled receptor-tyrosine-kinase targeting drugs for patient stratification and monitoring of therapy response: prospects and pitfalls.
    Tolmachev V; Stone-Elander S; Orlova A
    Lancet Oncol; 2010 Oct; 11(10):992-1000. PubMed ID: 20667780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Strategies for Breast Cancer Imaging: New Imaging Agents to Guide Treatment.
    McDonald ES; Mankoff DA; Mach RH
    J Nucl Med; 2016 Feb; 57 Suppl 1():69S-74S. PubMed ID: 26834105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligands for mapping alphavbeta3-integrin expression in vivo.
    Schottelius M; Laufer B; Kessler H; Wester HJ
    Acc Chem Res; 2009 Jul; 42(7):969-80. PubMed ID: 19489579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorescence imaging of bombesin and transferrin receptor expression is comparable to 18F-FDG PET in early detection of sorafenib-induced changes in tumor metabolism.
    Tseng JC; Narayanan N; Ho G; Groves K; Delaney J; Bao B; Zhang J; Morin J; Kossodo S; Rajopadhye M; Peterson JD
    PLoS One; 2017; 12(8):e0182689. PubMed ID: 28792505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifunctional aptamer-silver conjugates as theragnostic agents for specific cancer cell therapy and fluorescence-enhanced cell imaging.
    Li H; Hu H; Zhao Y; Chen X; Li W; Qiang W; Xu D
    Anal Chem; 2015 Apr; 87(7):3736-45. PubMed ID: 25686206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.